Kaufman Rossin Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kaufman Rossin Wealth's LLY Position: Q3 2026 in Review
Kaufman Rossin Wealth increased its Eli Lilly (LLY) stake by 87% in Q3 2026, buying an estimated $271K and bringing the position to 495 shares worth $572K. The position accounts for 0.23% of the portfolio, ranked #47.
Kaufman Rossin Wealth first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Kaufman Rossin Wealth held 495 shares of Eli Lilly worth $572K as of Q3 2026.
- Kaufman Rossin Wealth bought 230 Eli Lilly shares in Q3 2026, an estimated $271K.
- Eli Lilly made up 0.23% of Kaufman Rossin Wealth's portfolio in Q3 2026, its #47 holding.
- Kaufman Rossin Wealth first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
- 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Kaufman Rossin Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.